Breaking News, Financial News

Financial Report: Draxis

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Draxis Health 1Q Revenues: $21 million (+10%) 1Q Earnings: $2 million (+19%) Comments: Contract manufacturing revenues for 1Q2007 were $14.2 million (+5%), due to new product introduction activities. The result was weaker compared to the fourth quarter of 2006 due in part to a delay in receiving components for Hectorol production, which resulted in reduced volumes manufactured during the quarter. Sterile products represented approximately 78% of manufacturing revenues compared to 81% fo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters